1. Home
  2. AGIO vs NN Comparison

AGIO vs NN Comparison

Compare AGIO & NN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGIO
  • NN
  • Stock Information
  • Founded
  • AGIO 2007
  • NN 2007
  • Country
  • AGIO United States
  • NN United States
  • Employees
  • AGIO N/A
  • NN N/A
  • Industry
  • AGIO Biotechnology: Pharmaceutical Preparations
  • NN Industrial Machinery/Components
  • Sector
  • AGIO Health Care
  • NN Industrials
  • Exchange
  • AGIO Nasdaq
  • NN Nasdaq
  • Market Cap
  • AGIO 2.0B
  • NN 2.2B
  • IPO Year
  • AGIO 2013
  • NN N/A
  • Fundamental
  • Price
  • AGIO $33.23
  • NN $13.93
  • Analyst Decision
  • AGIO Buy
  • NN
  • Analyst Count
  • AGIO 7
  • NN 0
  • Target Price
  • AGIO $56.33
  • NN N/A
  • AVG Volume (30 Days)
  • AGIO 975.9K
  • NN 1.8M
  • Earning Date
  • AGIO 02-13-2025
  • NN 03-12-2025
  • Dividend Yield
  • AGIO N/A
  • NN N/A
  • EPS Growth
  • AGIO N/A
  • NN N/A
  • EPS
  • AGIO 11.80
  • NN N/A
  • Revenue
  • AGIO $32,871,000.00
  • NN $4,963,000.00
  • Revenue This Year
  • AGIO $33.41
  • NN $46.32
  • Revenue Next Year
  • AGIO $172.14
  • NN $43.50
  • P/E Ratio
  • AGIO $2.78
  • NN N/A
  • Revenue Growth
  • AGIO 36.79
  • NN 43.44
  • 52 Week Low
  • AGIO $21.18
  • NN $3.55
  • 52 Week High
  • AGIO $62.58
  • NN $18.54
  • Technical
  • Relative Strength Index (RSI)
  • AGIO 36.88
  • NN 46.79
  • Support Level
  • AGIO $31.39
  • NN $12.33
  • Resistance Level
  • AGIO $35.03
  • NN $13.48
  • Average True Range (ATR)
  • AGIO 1.71
  • NN 1.32
  • MACD
  • AGIO 0.54
  • NN -0.16
  • Stochastic Oscillator
  • AGIO 39.91
  • NN 51.18

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.

About NN NextNav Inc.

NextNav Inc provides GPS service. The company NextNav TerraPoiNT system keeps critical infrastructure resilient with reliable Position, Navigation and Timing services in the absence of GPS.

Share on Social Networks: